ES2040210T3 - Polipeptido para uso en dirigirlo a sitios diana e identificar linfocitos t activados. - Google Patents

Polipeptido para uso en dirigirlo a sitios diana e identificar linfocitos t activados.

Info

Publication number
ES2040210T3
ES2040210T3 ES198686308172T ES86308172T ES2040210T3 ES 2040210 T3 ES2040210 T3 ES 2040210T3 ES 198686308172 T ES198686308172 T ES 198686308172T ES 86308172 T ES86308172 T ES 86308172T ES 2040210 T3 ES2040210 T3 ES 2040210T3
Authority
ES
Spain
Prior art keywords
diana
polypeptide
directing
sites
activated lymphocytes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198686308172T
Other languages
English (en)
Inventor
Thorfinn Ege
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GE Healthcare AS
Original Assignee
Nycomed AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed AS filed Critical Nycomed AS
Application granted granted Critical
Publication of ES2040210T3 publication Critical patent/ES2040210T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

OBJETIVIZACION DE POLIPEPTIDOS PARA USO EN LA OBJETIVIZACION E IDENTIFICACION DE LINFOCITOS T - ACTIVADOS EN EL CUERPO HUMANO O DE ANIMALES, DICHOS POLIPEPTIDOS OBJETIVABLES SIENDO CAPACES DE ENLAZAR ESPECIFICAMENTE A LOS RECEPTORES DE INTERLEUQUINA - 2 DE LINFOCITOS T ACTIVADOS O A MOLECULAS ASOCIADAS CON DICHOS RECEPTORES Y PORTANDO UNO O MAS AGENTES DE IMAGEN COMPATIBLES FISIOLOGICAMENTE. DICHOS POLIPEPTIDOS OBJETIVABLES PUEDEN SER USADOS TAL COMO EN LA LOCALIZACION DE TUMORES, ABCESOS Y OTRAS CONDICIONES INFLAMATORIAS, Y EN LA MONITORIZACION DE TRASPLANTES DE TEJIDO PARA DETECTAR POSIBLES RECHAZOS.
ES198686308172T 1985-10-22 1986-10-21 Polipeptido para uso en dirigirlo a sitios diana e identificar linfocitos t activados. Expired - Lifetime ES2040210T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858525974A GB8525974D0 (en) 1985-10-22 1985-10-22 Chemical substance

Publications (1)

Publication Number Publication Date
ES2040210T3 true ES2040210T3 (es) 1993-10-16

Family

ID=10587035

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198686308172T Expired - Lifetime ES2040210T3 (es) 1985-10-22 1986-10-21 Polipeptido para uso en dirigirlo a sitios diana e identificar linfocitos t activados.

Country Status (8)

Country Link
US (1) US4832940A (es)
EP (1) EP0236619B1 (es)
JP (1) JP2727074B2 (es)
AT (1) ATE71306T1 (es)
DE (1) DE3683368D1 (es)
ES (1) ES2040210T3 (es)
GB (1) GB8525974D0 (es)
NO (1) NO174326C (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5330896A (en) * 1983-02-24 1994-07-19 Billing Ronald J Monoclonal antibodies to an autocrine growth factor antigen that binds to activated lymphocytes and cancer cells
JPH07110815B2 (ja) * 1985-11-18 1995-11-29 ボ−ド・オブ・リ−ジェンツ、ザ・ユニバ−シティ−・オブ・テキサス・システム 画像及びスペクトル向上（およびスペクトルシフト）のためのポリキレ−ト剤
US5679323A (en) * 1986-07-03 1997-10-21 Advanced Magnetics, Inc. Hepatocyte-specific receptor-mediated endocytosis-type compositions
US5342607A (en) * 1986-07-03 1994-08-30 Advanced Magnetics, Inc. Receptor mediated endocytosis type magnetic resonance imaging contrast agents
US5352432A (en) * 1986-07-03 1994-10-04 Advanced Magnetics, Inc. Hepatocyte specific composition and their use as diagnostic imaging agents
US6461825B1 (en) * 1987-09-30 2002-10-08 Sanofi (Societe Anonyme) Immunometric assay kit and method applicable to whole cells
EP0670167A1 (en) * 1988-08-04 1995-09-06 Advanced Magnetics Incorporated Receptor mediated endocytosis type diagnostic agents
US4986979A (en) * 1989-03-14 1991-01-22 Neorx Corporation Imaging tissue sites of inflammation
US5686410A (en) * 1989-07-20 1997-11-11 Novartis Ag Polypeptide derivatives
EP0485664A1 (en) * 1990-11-13 1992-05-20 Mallinckrodt Diagnostica (Holland) B.V. Method of preparing a diagnostic agent for detecting inflammations
US5997844A (en) * 1991-02-08 1999-12-07 Diatide, Inc. Technetium-99m labeled peptides for imaging
US5849261A (en) * 1991-02-08 1998-12-15 Diatide, Inc. Radiolabeled vasoactive intestinal peptides for diagnosis and therapy
US7238340B1 (en) 1991-11-27 2007-07-03 Cis Bio International Monoamine, diamide, thiol-containing metal chelating agents
US5965107A (en) * 1992-03-13 1999-10-12 Diatide, Inc. Technetium-99m labeled peptides for imaging
US5443815A (en) * 1991-11-27 1995-08-22 Diatech, Inc. Technetium-99m labeled peptides for imaging
US5783170A (en) * 1991-11-27 1998-07-21 Diatide, Inc. Peptide-metal chelate conjugates
US5508020A (en) * 1992-06-05 1996-04-16 Diatech, Inc. Technetium-99M labeled peptides for imaging
US5346686A (en) * 1992-10-05 1994-09-13 Mallinckrodt Medical, Inc. Labelled interleukin-8 and medical uses thereof
US5605671A (en) * 1992-10-05 1997-02-25 The Regents Of The University Of Michigan Radiolabeled neutrophil activating peptides for imaging
AU5537994A (en) * 1992-10-22 1994-05-09 Mallinckrodt Medical, Inc. Therapeutic treatment for inhibiting vascular restenosis
US5951964A (en) * 1993-06-04 1999-09-14 Diatide, Inc. Technetium-99m labeled peptides for imaging
US6008319A (en) 1996-12-23 1999-12-28 University Of Southern California Vasopermeability enhancing peptide of human interleukin-2 and immunoconjugates thereof
US7067111B1 (en) * 1999-10-25 2006-06-27 Board Of Regents, University Of Texas System Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging
EP2316494A1 (en) * 2000-06-02 2011-05-04 Board Of Regents, The University Of Texas Ethylenedicysteine (EC)-neomycin conjugates and their use in tissue specific disease imaging
ITRM20030159A1 (it) * 2003-04-07 2004-10-08 Uni Degli Studi Di Roma L A Sapienza Citochine radiomarcate e loro usi come traccianti scintigrafici per la visualizzazione delle infiammazioni croniche linfocito-mediate.
US9050378B2 (en) * 2003-12-10 2015-06-09 Board Of Regents, The University Of Texas System N2S2 chelate-targeting ligand conjugates
US8758723B2 (en) 2006-04-19 2014-06-24 The Board Of Regents Of The University Of Texas System Compositions and methods for cellular imaging and therapy
AU2007256626A1 (en) * 2006-06-06 2007-12-13 Rutgers, The State University Of New Jersey Iodinated polymers
US10925977B2 (en) 2006-10-05 2021-02-23 Ceil>Point, LLC Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications
IT201900011013A1 (it) 2019-07-05 2021-01-05 Sapienza Univ Di Roma Composto e composizione radiofarmaceutici per l’imaging con tecnica di Tomografia a Emissione di Positroni (PET) di cellule positive al recettore dell’interleuchina-2, processo per la loro preparazione, relativo kit e loro usi.

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4472371A (en) * 1979-10-29 1984-09-18 Summa Medical Corporation Radiolabeled antibody to anti-tumor associated antigen and process
DE3173342D1 (en) * 1980-03-03 1986-02-13 Milton David Goldenberg Agent for tumor localization and therapy with labeled antibodies and antibody fragments
US4473493A (en) * 1981-04-29 1984-09-25 Immunex Corporation Hybridoma antibody which inhibits interleukin 2 activity
US4454106A (en) * 1982-06-07 1984-06-12 Gansow Otto A Use of metal chelate conjugated monoclonal antibodies
US4443427A (en) * 1982-06-21 1984-04-17 Sidney Farber Cancer Institute, Inc. Monoclonal antibody
JPS59116231A (ja) * 1982-12-13 1984-07-05 スロ−ン−ケツタリング・インステイテユ−ト・フオ−・キヤンサ−・リサ−チ 抗−インタ−ロイキン−２単クロ−ン抗体
US4550086A (en) * 1983-02-16 1985-10-29 Dana-Farber Cancer Institute, Inc. Monoclonal antibodies that recognize human T cells
EP0149709B2 (en) * 1983-07-29 1995-11-29 Milton David Goldenberg Method for enhancing target specificity of antibody localization and clearance of non-target diagnostic and therapeutic principles
US4634586A (en) * 1984-05-21 1987-01-06 The Board Of Trustees Of The Leland Stanford Junior University Reagent and method for radioimaging leukocytes
US4578335A (en) * 1984-05-21 1986-03-25 Immunex Corporation Interleukin 2 receptor
US4695538A (en) * 1984-06-01 1987-09-22 Sloan-Kettering Institute For Cancer Research Human monoclonal antibodies to cell surface antigens
CA1260827A (en) * 1984-08-31 1989-09-26 Richard C. Siegel Antibody-metal ion complexes

Also Published As

Publication number Publication date
US4832940A (en) 1989-05-23
NO864203L (no) 1987-04-23
EP0236619B1 (en) 1992-01-08
ATE71306T1 (de) 1992-01-15
NO174326B (no) 1994-01-10
JPS62187498A (ja) 1987-08-15
GB8525974D0 (en) 1985-11-27
JP2727074B2 (ja) 1998-03-11
NO174326C (no) 1994-04-20
NO864203D0 (no) 1986-10-21
EP0236619A1 (en) 1987-09-16
DE3683368D1 (de) 1992-02-20

Similar Documents

Publication Publication Date Title
ES2040210T3 (es) Polipeptido para uso en dirigirlo a sitios diana e identificar linfocitos t activados.
DE69014474D1 (de) Antikörper gegen TNF-Bindungsprotein I und deren F(ab)-Fragmente.
BR8707612A (pt) Dispositivo para uso no manuseio de fluidos corporais
DE3689784D1 (de) Das kationische Merichinon eines Benzidins enthaltende ionische Komponenten, diese enthaltende Testkombinationen und deren Gebrauch bei Untersuchungen.
EP0188256A3 (en) Metal radionuclide labeled proteins for diagnosis and therapy
ES8506087A1 (es) Procedimiento para preparar proteina de uroquinasa humana bioactiva
SE8000470L (sv) Vevnadsbindmedel och forfarande for dess framstellning samt bindmedlets anvendning
BR8503367A (pt) Instrumento cirurgico para unir tecido por meio de um dispositivo de uniao de duas partes e grampo cirurgico polimerico biologicamente aceitavel para unir tecido humano ou animal e receptor para intertravar com o grampo
DE69531958D1 (de) (1-3)-beta-d-glukon-bindungsprotein, antikörper der dieses protein erkennt undverwendung des proteins und antikörper
DE3671970D1 (de) Probekoerper fuer ultraschallpruefung.
BR9003001A (pt) Prendedor e juncao de esteira
IL60948A (en) Flavin adenine dinucleotide-labeled protein or polypeptide conjugates and their use in immunoassay methods
DE69714451D1 (de) Prionbindende proteine und deren verwendungen
EP0336779A3 (en) Polypeptides stabilized by covalent hydrogen bond replacements
BR9509509A (pt) Derivados pirazolil-pirazol substituídos processos para sua preparação e seu uso como agentes com ação herbicida
ES8501630A1 (es) Un metodo para detectar o vigilar el estado de una condicion patologica humana que implica proteina de tejido conjuntivo.
DE3887053D1 (de) Stlv-iii-verwandte polypeptide, diagnosesysteme und testmethoden.
ES2061566T3 (es) Anticuerpos monoclonales contra la proteina e7 del papilomavirus humano tipo 16, procedimiento para su preparacion, asi como su empleo.
DE69003958D1 (de) Laser mit Halterungsvorrichtung des aktiven Materials und Halterungsvorrichtung für den Laseraufbau.
DE3686766D1 (de) Monoklonaler antikoerper gegen glutathion s-transferase und dessen verwendung zur diagnose von krebs.
ES2046187T3 (es) Anticuerpos para uso en la determinacion de la glucoalbumina humana.
FI971879A0 (fi) Allogeenisten ja ksenogeenisten proteiinien vasta-aineet, niiden käyttö diagnoosissa ja hoidossa ja menetelmät niiden määrittämiseksi
BR0008370A (pt) Proteìnas de fusão de glicose deshidrogenase e uso das mesmas em sistemas de expressão
ES272133Y (es) Contenedor perfeccionado, para uso en laboratorios, bancos de sangre y similares.
DE3886032D1 (de) Hiv-1-verwandte polypeptide, diagnosesysteme und testverfahren.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 236619

Country of ref document: ES